E-LIB Suche - Ergebnisse für: Nichols, David P.

1

Prospective evaluation of nontuberculous mycobacteria disea..:

Martiniano, Stacey L. ; Caceres, Silvia M. ; Poch, Katie...
Journal of Cystic Fibrosis. 23 (2024) 1 - p. 50-57 , 2024

2

The effect of discontinuing hypertonic saline or dornase al..:

Donaldson, Scott H. ; Corcoran, Timothy E. ; Pilewski, Joseph M....
Journal of Cystic Fibrosis. 23 (2024) 3 - p. 457-460 , 2024

Link: https://doi.org/10.1016/..

3

Effect of elexacaftor/tezacaftor/ivacaftor on mucus and muc..:

Donaldson, Scott H. ; Corcoran, Timothy E. ; Pilewski, Joseph M....
Journal of Cystic Fibrosis. 23 (2024) 1 - p. 155-160 , 2024

Link: https://doi.org/10.1016/..

4

Longitudinal improvements in clinical and functional outcom..:

Vijaykumar, Kadambari ; Leung, Hui Min ; Barrios, Amilcar...
Heliyon. 10 (2024) 8 - p. e29188 , 2024

Link: https://doi.org/10.1016/..

5

The impact of elexacaftor/tezacaftor/ivacaftor on fat-solub..:

Hergenroeder, Georgene E ; Faino, Anna ; Bridges, Gracia...
Journal of Cystic Fibrosis. 22 (2023) 6 - p. 1048-1053 , 2023

Link: https://doi.org/10.1016/..

6

Polymicrobial infections and antibiotic treatment patterns ..:

Faino, Anna V. ; Hoffman, Lucas R. ; Gibson, Ronald L....
Journal of Cystic Fibrosis. 22 (2023) 4 - p. 630-635 , 2023

Link: https://doi.org/10.1016/..

7

Pharmacologic improvement of CFTR function rapidly decrease..:

Nichols, David P. ; Morgan, Sarah J. ; Skalland, Michelle...
Journal of Clinical Investigation. 133 (2023) 10 - p. , 2023

Link: https://doi.org/10.1172/..

8

Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outco..:

Schwarzenberg, Sarah Jane ; Vu, Phuong T. ; Skalland, Michelle...
Journal of Cystic Fibrosis. 22 (2023) 2 - p. 282-289 , 2023

Link: https://doi.org/10.1016/..

9

Embrace subjectivity: existentially-informed clinical psych..:

Pashak, Travis J. ; Nelson, Olivia M. ; Tunstull, Makiya D....
Clinical Psychologist. 27 (2022) 1 - p. 4-21 , 2022

Link: https://doi.org/10.1080/..

10

Blood mRNA biomarkers distinguish variable systemic and spu..:

Caceres, Silvia M. ; Sanders, Linda A. ; Rysavy, Noel M....
PLOS ONE. 17 (2022) 5 - p. e0267592 , 2022

Link: https://doi.org/10.1371/..

11

Drugs, Drugs, Drugs: Current Treatment Paradigms in Cystic ..:

Cogen, Jonathan D ; Nichols, David P ; Goss, Christopher H.
Journal of the Pediatric Infectious Diseases Society. 11 (2022) Supplement_2 - p. S32-S39 , 2022

Link: https://doi.org/10.1093/..

12

Association Between Number of Intravenous Antipseudomonal A..:

Cogen, Jonathan D ; Faino, Anna V ; Onchiri, Frankline...
Clinical Infectious Diseases. 73 (2021) 9 - p. 1589-1596 , 2021

Link: https://doi.org/10.1093/..

13

Testing the effects of combining azithromycin with inhaled ..:

Nichols, David P ; Singh, Pradeep K ; Baines, Arthur...
Thorax. 77 (2021) 6 - p. 581-588 , 2021

Link: https://doi.org/10.1136/..

14

The impact of SARS-CoV-2 on the cystic fibrosis foundation ..:

Pearson, Kelsie ; Mayer-Hamblett, Nicole ; Goss, Christopher H....
Journal of Cystic Fibrosis. 20 (2021) 2 - p. 195-197 , 2021

Link: https://doi.org/10.1016/..

15

Answering the call to address cystic fibrosis treatment bur..:

Gifford, Alex H. ; Mayer-Hamblett, Nicole ; Pearson, Kelsie.
Journal of Cystic Fibrosis. 19 (2020) 5 - p. 762-767 , 2020

Link: https://doi.org/10.1016/..